David J. Resnick

David Resnick practices at Allergy & Asthma Consultants of Rockland and Bergen in West Nyack, New York.

David Resnick's NPI, 1922064435, was assigned on April 24, 2006. David Resnick graduated from SUNY Downstate Health Sciences University in 1986. David Resnick holds New York license 173338.

David Resnick's primary practice is Allergy & Asthma Consultants of Rockland and Bergen, at 2 Cros Field Ave, West Nyack, NY 10994 in Rockland County. The practice phone is (845) 353-9600.

David Resnick's primary practice is Allergy & Asthma Consultants of Rockland and Bergen in West Nyack, New York. The medical group on file is Allergy and Asthma Consultants of Rockland and Bergen. Dmand AI also links David Resnick to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where David Resnick practices. Vendor and product names are available with a free account.

Pediatric allergy/immunology is David Resnick's primary specialty in the NPI Registry, under taxonomy code 2080P0201X. David Resnick is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has David Resnick's licenses on file in 2 states: New York and Connecticut.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives and immune deficiency disease among the conditions David Resnick treats.

CMS data shows 1,632 Medicare services from David Resnick across 11 procedure codes in 2024, for 245 Medicare patients. Medicare paid $40,865 for them. Every service was in an office.

CMS counts 245 Medicare patients who saw David Resnick in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Resnick's median patient age at 33, with 55% women.

In 2024, David Resnick wrote 1,652 Medicare Part D claims for 261 patients. 66% of them were for generic drugs. CMS names the drug for 1,483 of them, across 27 drugs with 11 or more claims each, at $1,845,768 in total drug cost. In 2023, CMS named 1,318 claims across 32 drugs.

David Resnick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to David Resnick, published from 2010 to 2012. The most frequent topics are Asthma, Angioedemas, Hereditary and Bradykinin. David Resnick has published most often in Ann Allergy Asthma Immunol. David Resnick's most frequent co-authors are Jonathan A. Bernstein, MD, Stephen Marc Canfield, MD and William Raymond Lumry, MD.

CMS Open Payments shows 35 general payments to David Resnick from 12 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 76% of the total. GlaxoSmithKline, LLC. paid the most, $180.

Dmand AI lists 6 awards for David Resnick, most recently Super Doc in 2013. David Resnick serves on Eosinophilic Esophagitis.

David Resnick graduated from SUNY Downstate Health Sciences University in 1986. David Resnick is a member of AAAAI and AAP.

David Resnick is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.